BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35773081)

  • 1. First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.
    Savari O; Chang JC; Bishop JA; Sakthivel MK; Askin FB; Rekhtman N
    J Thorac Oncol; 2022 Aug; 17(8):1050-1053. PubMed ID: 35773081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.
    Kuo YJ; Lewis JS; Zhai C; Chen YA; Chernock RD; Hsieh MS; Lan MY; Lee CK; Weinreb I; Hang JF
    Mod Pathol; 2021 Oct; 34(10):1820-1830. PubMed ID: 34108636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
    Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
    Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity.
    Todorovic E; Truong T; Eskander A; Lin V; Swanson D; Dickson BC; Weinreb I
    Am J Surg Pathol; 2020 Sep; 44(9):1244-1250. PubMed ID: 32366754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEK::AFF2 Fusion Carcinomas of Head and Neck.
    Ruangritchankul K; Sandison A
    Adv Anat Pathol; 2023 Mar; 30(2):86-94. PubMed ID: 36221219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract.
    Kuo YJ; Lewis JS; Truong T; Yeh YC; Chernock RD; Zhai C; Chen YA; Hongo T; Lee CK; Shi Q; Velez Torres JM; Geromes AB; Chu YH; Hsieh MS; Yamamoto H; Weinreb I; Hang JF
    Mod Pathol; 2022 Nov; 35(11):1587-1595. PubMed ID: 35701667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas.
    Ng JKM; Chow C; Tang CY; Chan AZ; Li JJX; Chan ABW
    Virchows Arch; 2024 Jan; 484(1):119-125. PubMed ID: 38063896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.
    Miller DL; Palsgrove DN; Rijal A; Hathuc V; Chernock R; Gagan J; Bishop JA
    Head Neck Pathol; 2022 Sep; 16(3):928-933. PubMed ID: 35218513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
    Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
    Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the DEK oncogene in the development of squamous cell carcinoma.
    Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
    Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The First Report of Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma on Fine-Needle Aspiration.
    Li JJX; Ng JKM; Chan ABW
    Head Neck Pathol; 2023 Dec; 17(4):1058-1063. PubMed ID: 37938508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature.
    Yuzawa S; Michizuka T; Kakisaka R; Ono Y; Hayashi M; Takahara M; Katada A; Mizukami Y; Tanino M
    Diagn Pathol; 2023 Apr; 18(1):44. PubMed ID: 37041626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diagnostic algorithm for sinonasal papillary non-keratinizing squamous cell carcinoma with DEK::AFF2 fusion and mimickers.
    Laforga JB; Othman BK
    Rev Esp Patol; 2024; 57(1):67-70. PubMed ID: 38246714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary DEK::AFF2 fusion positive nonkeratinizing squamous cell carcinoma of the middle ear: report of a case].
    Yu ST; Ye XZ; Xu BQ; Ouyang XJ; Zhang JQ; Qu LJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1058-1060. PubMed ID: 37805405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
    Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
    Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonkeratinizing Squamous Cell Carcinoma of the Sinonasal Tract With DEK-AFF2: Further Solidifying an Emerging Entity.
    Bishop JA; Gagan J; Paterson C; McLellan D; Sandison A
    Am J Surg Pathol; 2021 May; 45(5):718-720. PubMed ID: 33002918
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
    Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, DEK::AFF2 Fusion, and MAML2 Rearrangement.
    Holliday D; Mehrad M; Ely KA; Tong F; Wang X; Hang JF; Kuo YJ; Velez-Torres JM; Lott-Limbach A; Lewis JS
    Head Neck Pathol; 2023 Jun; 17(2):487-497. PubMed ID: 36849671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.
    Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
    Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
    Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
    Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.